Rowan Chapman, PhD
Head of Innovation, Johnson & Johnson
Rowan is the Head of Johnson & Johnson Innovation, California. In this role, Rowan leads the California team to build and manage a portfolio of co-investments spanning all three sectors of Johnson & Johnson.
Rowan most recently served as Head of Healthcare Investing, GE Ventures. There she led the team responsible for GE Ventures’ healthcare investing strategy and portfolio as well as managing partnerships and thought leadership with a particular focus on digital health, data analytics and precision medicine. In this role she drove creation of the first three Healthcare “NewCos” incubated and launched from GE. Prior to joining the ventures team, Rowan served as Head of Precision Diagnostics at GE Healthcare, where she was responsible for strategy development to integrate lab services, products, data, informatics, software, and content. Before GE, she spent 11 years as a Partner at Mohr Davidow Ventures, where she drove development of the life science investment strategy and practice area. Her investments ranged from therapeutics to diagnostic to digital.
Rowan holds a PhD and first class honors degree in Biochemistry from Cambridge University, U.K. and was a post-doctoral fellow at the University of California, San Francisco
Featured In + Download Agenda As PDF
Building New Competencies: Which Innovation Model is Right for You?
Competing in a digital world requires talent and technologies that you may not have in-house. How do you develop a strategy to source these capabilities? This panel will examine how large incumbents acquire new innovative capabilities from identifying and investing in startups, to innovation labs, to partnering, and acquisition.